Canature Health Technology Group Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Industrial Manufacturing
  • ISIN: CNE1000018L9
CNY
7.57
0.04 (0.53%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Net Sales
417.61
466.32
483.85
412.72
434.46
424.71
447.94
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
417.61
466.32
483.85
412.72
434.46
424.71
447.94
Raw Material Cost
256.79
289.01
294.61
244.45
291.49
266.25
274.62
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
10.69
9.21
8.53
9.40
9.56
7.89
8.79
Selling and Distribution Expenses
96.05
99.96
95.83
100.99
111.94
90.61
95.42
Other Expenses
0.67
0.85
0.62
0.70
1.07
0.51
0.49
Total Expenditure (Excl Depreciation)
370.26
406.69
405.15
361.80
423.67
369.81
383.78
Operating Profit (PBDIT) excl Other Income
47.300000000000004
59.6
78.7
50.9
10.8
54.900000000000006
64.2
Other Income
-5.13
5.39
5.13
6.21
28.38
-4.88
14.84
Operating Profit (PBDIT)
39.22
62.57
99.91
53.98
51.25
68.06
95.37
Interest
10.69
9.21
8.53
9.40
9.56
7.89
8.79
Exceptional Items
-1.10
0.00
-0.00
-0.03
-3.00
0.00
0.00
Gross Profit (PBDT)
160.82
177.31
189.24
168.28
142.97
158.46
173.31
Depreciation
0.00
0.00
19.23
0.00
20.09
20.09
19.77
Profit Before Tax
27.42
53.36
72.15
44.55
18.59
40.07
66.81
Tax
5.91
6.82
7.88
8.66
-1.09
2.52
15.03
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
5.34
25.21
45.34
20.83
-0.59
27.13
34.74
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
5.34
25.21
45.34
20.83
-0.59
27.13
34.74
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
7.47
6.61
8.36
9.13
4.40
9.31
9.11
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
12.82
31.82
53.70
29.96
3.81
36.45
43.85
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
1,264.26
1,436.96
1,261.28
1,246.24
1,222.72
1,252.39
1,248.96
Earnings per share (EPS)
0.01
0.04
0.08
0.04
-0.0
0.05
0.06
Diluted Earnings per share
0.01
0.04
0.08
0.04
-0.0
0.05
0.06
Operating Profit Margin (Excl OI)
10.62%
12.26%
15.62%
11.58%
0.64%
12.44%
13.57%
Gross Profit Margin
6.57%
11.44%
18.89%
10.8%
8.9%
14.17%
19.33%
PAT Margin
1.28%
5.41%
9.37%
5.05%
-0.14%
6.39%
7.76%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Mar 2026 is 1.19% vs 8.21% in Mar 2025

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Mar 2026 is -57.33% vs 2.39% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Mar 2026 is -7.32% vs -18.15% in Mar 2025

stock-summary

Interest

YoY Growth in quarter ended Mar 2026 is 13.83% vs 14.63% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025

Compare Quarterly Results Of Canature Health Technology Group Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
417.61
0
417.61
Other Operating Income
0.00
0.00
0.00
Total Operating income
417.61
0
417.61
Raw Material Cost
256.79
0
256.79
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
10.69
0
10.69
Selling and Distribution Expenses
96.05
0
96.05
Other Expenses
0.67
0.00
0.67
Total Expenditure (Excl Depreciation)
370.26
0
370.26
Operating Profit (PBDIT) excl Other Income
47.34
0.00
47.34
Other Income
-5.13
0
-5.13
Operating Profit (PBDIT)
39.22
0
39.22
Interest
10.69
0
10.69
Exceptional Items
-1.10
0
-1.10
Gross Profit (PBDT)
160.82
0
160.82
Depreciation
0.00
0
0.00
Profit Before Tax
27.42
0
27.42
Tax
5.91
0
5.91
Provisions and contingencies
0
0
0.00
Profit After Tax
5.34
0
5.34
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
5.34
0
5.34
Share in Profit of Associates
0
0
0.00
Minority Interest
7.47
0
7.47
Other related items
0.00
0.00
0.00
Consolidated Net Profit
12.82
0
12.82
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
1,264.26
0
1,264.26
Earnings per share (EPS)
0.01
0
0.01
Diluted Earnings per share
0.01
0
0.01
Operating Profit Margin (Excl OI)
10.62%
0%
0.00
10.62%
Gross Profit Margin
6.57%
0%
0.00
6.57%
PAT Margin
1.28%
0%
0.00
1.28%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 41.76 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -10.44% vs -3.64% in Sep 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 1.19% vs 8.21% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 1.28 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -59.75% vs -40.78% in Sep 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -57.33% vs 2.39% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 4.43 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -22.55% vs -39.66% in Sep 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -7.32% vs -18.15% in Mar 2025

Quarterly - Interest
Interest 1.07 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 16.30% vs 8.24% in Sep 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 13.83% vs 14.63% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 10.62%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has fallen from Sep 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025